SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 194 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $61,457 | -32.1% | 48,391 | +16.5% | 0.00% | 0.0% |
Q3 2021 | $90,531 | -21.0% | 41,528 | +35.8% | 0.00% | -50.0% |
Q2 2021 | $114,664 | -8.5% | 30,577 | -20.5% | 0.00% | 0.0% |
Q1 2021 | $125,363 | -13.3% | 38,455 | -9.3% | 0.00% | 0.0% |
Q4 2020 | $144,557 | -17.1% | 42,392 | -0.8% | 0.00% | -33.3% |
Q3 2020 | $174,400 | +35.9% | 42,745 | +12.6% | 0.00% | +50.0% |
Q2 2020 | $128,335 | +44.4% | 37,969 | -0.4% | 0.00% | 0.0% |
Q1 2020 | $88,845 | -32.0% | 38,131 | +6.2% | 0.00% | 0.0% |
Q4 2019 | $130,720 | -58.1% | 35,912 | -4.4% | 0.00% | -60.0% |
Q3 2019 | $311,668 | +8.1% | 37,573 | +12.2% | 0.01% | 0.0% |
Q2 2019 | $288,211 | -16.7% | 33,474 | +3.4% | 0.01% | -16.7% |
Q1 2019 | $346,025 | +22.2% | 32,369 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $283,229 | -47.9% | 32,369 | 0.0% | 0.01% | -40.0% |
Q3 2018 | $543,799 | -99.9% | 32,369 | 0.0% | 0.01% | -9.1% |
Q2 2018 | $678,454,000 | +49.6% | 32,369 | +14.8% | 0.01% | +83.3% |
Q1 2018 | $453,545,000 | +86952.8% | 28,188 | +2.5% | 0.01% | -14.3% |
Q4 2017 | $521,000 | -36.6% | 27,512 | -52.9% | 0.01% | +40.0% |
Q3 2017 | $822,000 | +87.7% | 58,400 | -0.7% | 0.01% | +66.7% |
Q2 2017 | $438,000 | +14.7% | 58,831 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $382,000 | +60.5% | 58,831 | +9.5% | 0.00% | +50.0% |
Q4 2016 | $238,000 | -14.1% | 53,720 | -9.4% | 0.00% | 0.0% |
Q3 2016 | $277,000 | -16.3% | 59,287 | +17.7% | 0.00% | 0.0% |
Q2 2016 | $331,000 | +11.8% | 50,358 | +8.2% | 0.00% | 0.0% |
Q1 2016 | $296,000 | +5.3% | 46,555 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $281,000 | +1.1% | 46,555 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $278,000 | -9.2% | 46,555 | +4.0% | 0.00% | 0.0% |
Q2 2015 | $306,000 | +2.7% | 44,768 | -8.8% | 0.00% | 0.0% |
Q1 2015 | $298,000 | -12.6% | 49,090 | -0.1% | 0.00% | 0.0% |
Q4 2014 | $341,000 | -14.8% | 49,135 | 0.0% | 0.00% | -33.3% |
Q3 2014 | $400,000 | +0.3% | 49,135 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $399,000 | +3.6% | 49,135 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $385,000 | -11.5% | 49,135 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $435,000 | +5.6% | 49,135 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $412,000 | +12.3% | 49,135 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $367,000 | – | 49,135 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |